Special Investigation Of Gabapen For Pediatric (Regulatory Post Marketing Commitment Plan)
Phase of Trial: Phase IV
Latest Information Update: 10 Oct 2016
At a glance
- Drugs Gabapentin (Primary)
- Indications Partial epilepsies
- Focus Adverse reactions; Therapeutic Use
- Sponsors Pfizer
- 03 Aug 2015 Status changed from active, no longer recruiting to completed, as reported by ClinicalTrials.gov.
- 08 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 20 Nov 2014 Planned End Date changed from 1 May 2015 to 1 Jun 2015, according to the ClinicalTrials.gov record.